Sign In  |  Register  |  About Corte Madera  |  Contact Us

Corte Madera, CA
September 01, 2020 10:27am
7-Day Forecast | Traffic

  • Search Hotels in Corte Madera

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Globus Medical Inc (NY: GMED )

46.51 +1.18 (+2.60%)
Official Closing Price Updated: 7:00 PM EST, Dec 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,123,547
Open 45.40
Bid (Size) 46.18 (1)
Ask (Size) 46.91 (1)
Prev. Close 45.33
Today's Range 45.21 - 46.63
52wk Range 43.38 - 80.04
Shares Outstanding 137,793,194
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
For those who appreciate growth without the sticker shock, NYSE:GMED is worth considering.
GLOBUS MEDICAL INC - A (NYSE:GMED) is not too expensive for the growth it is showing. 
Via Chartmill
NYSE:GMED: a strong growth stock preparing for the next leg up?.
GLOBUS MEDICAL INC - A (NYSE:GMED) qualifies as a high growth stock and is consolidating. 
Via Chartmill

Performance

YTD
-36.43%
-36.43%
1 Month
+5.97%
+5.97%
3 Month
-8.89%
-8.89%
6 Month
-18.22%
-18.22%
1 Year
-35.40%
-35.40%

More News

Read More
Investors should take note of NYSE:GMED, a growth stock that remains attractively priced.
Via Chartmill
Expert Ratings for Globus Medical
Via Benzinga
Globus Medical (GMED) Q3 2023 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Globus Medical: Q3 Earnings Insights
Via Benzinga
Globus Medical Reports Third Quarter 2023 Results
From Globus Medical
Via GlobeNewswire
NYSE:GMED is showing good growth, while it is not too expensive.
Via Chartmill
What 8 Analyst Ratings Have To Say About Globus Medical
Via Benzinga
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
From Globus Medical
Via GlobeNewswire
Five-Year Study Outcomes of the NuVasive Simplify Cervical Disc were Presented at the North American Spine Society 38th Annual Meeting
From Globus Medical
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2023
Via Benzinga
Twenty Years of the NuVasive XLIF Procedure Celebrated at the Society for Minimally Invasive Spine Surgery 2023 Annual Forum
From Globus Medical
Via GlobeNewswire
Globus Medical and NuVasive to Sponsor and Participate at EUROSPINE 2023
From Globus Medical
Via GlobeNewswire
Globus Medical's Untapped Potential Beyond The NUVA Transaction; Analyst Turns Bullish
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 19, 2023
Via Benzinga
The Latest Analyst Ratings for Globus Medical
Via Benzinga
Where Globus Medical Stands With Analysts
Via Benzinga
NuVasive Specialized Orthopedics Launches Precice Bone Transport in International Markets
From Globus Medical
Via GlobeNewswire
Globus Medical Completes Merger with NuVasive
From Globus Medical
Via GlobeNewswire
Globus Medical (GMED) Q2 2023 Earnings Call Transcript
Via The Motley Fool
Globus Medical Reports Second Quarter 2023 Results
From Globus Medical
Via GlobeNewswire
Expert Ratings for Globus Medical
Via Benzinga
Globus Medical Announces Launch of the MARVEL™ Growing Rod System, the company’s first product designed specifically for early onset scoliosis
From Globus Medical
Via GlobeNewswire
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
From Globus Medical
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 CorteMadera.com & California Media Partners, LLC. All rights reserved.